- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/7008 - Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
Patent holdings for IPC class A61K 31/7008
Total number of patents in this class: 660
10-year publication summary
|
58
|
55
|
57
|
48
|
48
|
46
|
59
|
33
|
27
|
23
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Amicus Therapeutics, Inc. | 354 |
20 |
| The Regents of the University of California | 20815 |
13 |
| FLE International S.r.l. | 39 |
10 |
| Société des Produits Nestlé S.A. | 10042 |
9 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3328 |
8 |
| The Johns Hopkins University | 5913 |
7 |
| Notogen, Inc. | 7 |
7 |
| Centre National de La Recherche Scientifique | 11059 |
6 |
| Purepharm Inc. | 35 |
6 |
| Boehringer Ingelheim International GmbH | 4486 |
5 |
| Pfizer Inc. | 3409 |
5 |
| Arrowhead Pharmaceuticals, Inc. | 354 |
5 |
| Farnam Companies, Inc. | 134 |
5 |
| Marine Polymer Technologies, Inc. | 62 |
5 |
| Tulex Pharmaceuticals Inc., DBA Tulex Pharmaceuticals Inc. | 24 |
5 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3010 |
5 |
| University Health Network | 1066 |
5 |
| The University of Melbourne | 568 |
5 |
| The University of Tokyo | 4378 |
5 |
| U.S. Nutraceuticals, L.L.C., DBA Valensa International | 26 |
5 |
| Other owners | 519 |